GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (BOM:543635) » Definitions » Net Margin %

Piramal Pharma (BOM:543635) Net Margin % : 3.97% (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. Piramal Pharma's Net Income for the three months ended in Mar. 2024 was ₹1,013 Mil. Piramal Pharma's Revenue for the three months ended in Mar. 2024 was ₹25,524 Mil. Therefore, Piramal Pharma's net margin for the quarter that ended in Mar. 2024 was 3.97%.

The historical rank and industry rank for Piramal Pharma's Net Margin % or its related term are showing as below:

BOM:543635' s Net Margin % Range Over the Past 10 Years
Min: -2.63   Med: 3   Max: 19.45
Current: 0.22


BOM:543635's Net Margin % is ranked worse than
58.64% of 1018 companies
in the Drug Manufacturers industry
Industry Median: 3.255 vs BOM:543635: 0.22

Piramal Pharma Net Margin % Historical Data

The historical data trend for Piramal Pharma's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Net Margin % Chart

Piramal Pharma Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Net Margin %
19.45 5.78 -2.63 0.22

Piramal Pharma Quarterly Data
Mar21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.32 -5.64 0.26 0.52 3.97

Competitive Comparison of Piramal Pharma's Net Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Piramal Pharma's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Piramal Pharma's Net Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Piramal Pharma's Net Margin % distribution charts can be found below:

* The bar in red indicates where Piramal Pharma's Net Margin % falls into.



Piramal Pharma Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Piramal Pharma's Net Margin for the fiscal year that ended in Mar. 2024 is calculated as

Net Margin=Net Income (A: Mar. 2024 )/Revenue (A: Mar. 2024 )
=178.2/81711.6
=0.22 %

Piramal Pharma's Net Margin for the quarter that ended in Mar. 2024 is calculated as

Net Margin=Net Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=1012.7/25523.6
=3.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Piramal Pharma  (BOM:543635) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Piramal Pharma Net Margin % Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Piramal Pharma (BOM:543635) Business Description

Traded in Other Exchanges
Address
Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070
Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (BOM:543635) Headlines

No Headlines